The GeoMx ® Cancer Transcriptome Atlas (CTA) is designed for a comprehensive profiling of tumor biology, the tumor microenvironment, and the immune response, with spatial resolution from distinct regions of interest with a single tissue section.
This panel allows you to profile the expression of over 1,800 genes covering around 100 pathways. You will be able to:
- Profile the global immune response
- Assess microenvironment immune activity
- Quantify tumor reactivity to the immune response and therapeutic treatments
- Profile heterogeneous tumors, covering clinically derived gene sets (Tumor Inflammation Signature (TIS), PAM50…)
Furthermore, it can be customized with up to 60 additional targets of interest.
The GeoMx® CTA is compatible with RNAscope® technology and antibody morphology markers for tissue imaging and ROIs selection.
The read out is performed by Next-Generation Sequencing (NGS), and the software GeoMx DSP data center provides an end-to-end software solution from image acquisition and region of interest selection to a fully integrated data analysis experience.
For more information about the pathways and processes included in the panel, please, consult the product file you can download below or visit the NanoString web:
